DRUG FIRMS MAY END CLASS-OF-TRADE PRICING

CHICAGO -- Some of the nation's largest drug manufacturers will stop two-tiered pricing practices if a tentative settlement is approved. Federal Court Judge Charles Korcoras gave the proposal preliminary approval on May 8. It will be discussed at a June 11 fairness hearing here in federal court. If approved, it would go into effect 90 days later and will remain binding for three years. The tentative

CHICAGO -- Some of the nation's largest drug manufacturers will stop two-tiered pricing practices if a tentative settlement is approved. Federal Court Judge Charles Korcoras gave the proposal preliminary approval on May 8. It will be discussed at a June 11 fairness hearing here in federal court. If approved, it would go into effect 90 days later and will remain binding for three years. The tentative deal came a month after Korcoras struck down a proposed $408.9 million settlement of an antitr

Register to view the full article

Already a member? .